Practice-based evidence: profiling the safety of cilostazol by text-mining of clinical notes.

<h4>Background</h4>Peripheral arterial disease (PAD) is a growing problem with few available therapies. Cilostazol is the only FDA-approved medication with a class I indication for intermittent claudication, but carries a black box warning due to concerns for increased cardiovascular mor...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Nicholas J Leeper, Anna Bauer-Mehren, Srinivasan V Iyer, Paea Lependu, Cliff Olson, Nigam H Shah
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2013
Materias:
R
Q
Acceso en línea:https://doaj.org/article/c71709a69fe1404caaa92460471a83d8
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares